New Phase 3 Trial of Non-opioid Pain Relief Tablet to Open in US, Tonix Says
News
Tonix Pharmaceuticals announced it is opening a new Phase 3 trial to evaluate the efficacy and safety of its investigational therapy TNX-102 SL, a sublingual tablet, in easing the widespread pain ... Read more